What's in the Cards for Amgen (AMGN) This Earnings Season?
https://www.zacks.com/stock/news/2264395/what-s-in-the-cards-for-amgen-amgn-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264395
Apr 29, 2024 - Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
0
Pages: 1
Page 1